Start by separating what is advertised from what is eventually prescribed. This review considers SuperHealthy Rx’s published NAD+ injections information through what the public documents establish. The source describes access to clinical assessment, rather than an over-the-counter purchase.
We read the official pages on October 4, 2026. The review reports their public terms and identifies questions still requiring an answer; it does not report treatment testing, pharmacy inspection or verified patient outcomes. Read the selected prescription and final order alongside this article because availability and prices can change.
Compare the named NAD+ injections offer, final invoice and clinical follow-up before committing.
Published starting offer. Confirm the final prescription, current availability and written terms.
Identify the actual offer
The NAD+ injectable page advertises a $299 starting price for a one-month supply. Its stated pathway is an online health assessment, medical-team review and pharmacy delivery when treatment is prescribed. The headline identifies an offer; it does not identify every possible prescription or establish personal eligibility.
The page also includes nasal-spray wording in its injectable presentation. Do not assume those routes are interchangeable. Request the exact route, concentration, quantity and dispensing-pharmacy label for the offer you select.
The clinician, pharmacy and follow-up
SuperHealthy describes an online health questionnaire followed by medical-team review. Completing an assessment does not guarantee a prescription. Identify the responsible clinician, their authorization for the state where you will receive care and the pharmacy that would dispense the medicine. A general statement about licensed care is not an independent inspection of every participant.
Ask how a question reaches the prescriber after delivery, whether a live visit is available and what happens if further assessment is needed. An account-support reply and medical advice serve different purposes. Keep the contact route and expected follow-up process in the written plan rather than relying on a sales-page promise of convenient support.
Compare the complete commitment
For this topic, the current public starting point is: From $299 for a one-month supply. Ask for the amount due today, supplied quantity, consultation and laboratory charges, shipping and any recurring payment. A rate expressed per month does not by itself establish a cancellable monthly contract.
Request the current cancellation and refund conditions before paying. Ask when an order is sent to a pharmacy, how refill authorization works and whether a declined prescription leaves an assessment fee. We did not complete checkout, so the review does not invent a refund window or promise that every charge is recoverable.
What this review cannot prove
NAD biology, an oral precursor study and a prescribed injection are separate evidence questions. A change in a biomarker is not proof that this service improves cognition, treats unexplained fatigue or extends life. Ask what clinical evidence supports the exact route and preparation being proposed.
Provider statements about convenience, energy or expected results should remain identified as marketing unless matching independent evidence is available. A commercial position in a comparison is not a finding of clinical superiority. The useful next step is a clinician conversation about the concern that brought you to the page and the reasonable alternatives.
Our assessment and the next question
SuperHealthy Rx adds another documented online assessment route to the NAD+ injections comparison. Its value as a reading option is the named offer and the questions it allows you to ask. The unresolved issues are the actual prescription, total selected commitment, pharmacy identity and continuing medical contact.
Bring this question to the service: “Which current product, supply period and care arrangement does my written quote cover, and who handles a clinical question before the next refill?” A complete answer will be more useful than treating a ranking number, ingredient name or low starting figure as a personal treatment recommendation.
Compare with the CoreAge Rx review and current SuperHealthy details.
Sources & reading notes
Editorial source review updated October 4, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- SuperHealthy Rx: official nad page Official page checked October 4, 2026; offer information is not outcome verification.
- FDA: ingredients suitable for sterile compounding Safety notice describing reported reactions and ingredient-quality concerns.
- FDA: compounding questions and answers Explains that compounded drugs are not FDA-approved.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.